Heartsciences INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
HeartSciences Inc. announces its 2026 Annual Meeting of Shareholders to address director election, an expanded equity incentive plan, officer liability exculpation, and auditor ratification.
NASDAQ
Heart Test Laboratories has filed a definitive proxy statement with the SEC.
NASDAQ
Heart Test Laboratories, Inc. announces its Annual Meeting of Shareholders to be held virtually on November 7, 2024, seeking shareholder approval on key proposals including the ratification of its independent accounting firm.